CPHI vs NVR · rev $4.1M vs P/E 15, rev $10.52B
China Pharma Holdings Inc (CPHI) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
CPHI currently screens at market cap $29.0M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the CPHI and NVR stock pages for the full models.
Not investment advice.